Enhanced intensity scaling testing
Objective measurement data and active learning techniques improve the efficiency and accuracy of intensity scaling tests for medical devices by reducing subjectivity and duration, ensuring precise and personalized device settings.
Patent Information
- Application Number
- PCT/IB2026/054448
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-12
- Filing Date
- 2026-05-05
- Publication Date
- 2026-11-19
AI Technical Summary
Conventional intensity scaling tests for medical devices, particularly hearing aids and cochlear implants, are lengthy, prone to subjective bias, fatiguing for users, and inconsistent due to environmental noise and individual perception differences, leading to inaccurate and time-consuming fitting processes.
Implementing objective measurement data, such as amplitude growth functions derived from evoked compound action potentials, combined with active learning techniques, to control intensity scaling tests, reducing subjectivity and duration, and using historical data for personalized settings.
Enhances the efficiency, accuracy, and reliability of intensity scaling tests by minimizing user fatigue, response bias, and environmental noise effects, resulting in quicker and more precise device fitting.
Smart Images

Figure IB2026054448_19112026_PF_FP_ABST
Abstract
Description
Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1ENHANCED INTENSITY SCALING TESTINGBACKGROUNDField of the Invention[ooot] The present invention relates generally to intensity (e.g., loudness) scaling testing for a recipient stimulation device.Related Art
[0002] Medical devices are devices that are intended to be used for medical purposes. They can vary in both their intended use and indications for use. Examples range from simple, low-risk medical supplies to complex, potentially high-risk devices that are implanted and / or sustain life, such as deep brain stimulators and brain-computer interfaces. Other categories of medical device include diagnostic equipment.
[0003] Hearing devices act on an actual or potential auditory perception of an individual, including to improve perception of sound signals, to reduce perception of sound signals, etc. In particular, a hearing device can deliver sound signals to a user in any form, including in the form of acoustical stimulation, mechanical stimulation, electrical stimulation, etc., and / or can operate to suppress all or some sound signals. As such, a hearing device can be a device for use by a hearing-impaired person (e.g., hearing aids, middle ear auditory prostheses, bone conduction devices, direct acoustic stimulators, electro-acoustic hearing prostheses, auditory brainstem stimulators, bimodal hearing prostheses, bilateral hearing prostheses, dedicated tinnitus therapy devices, tinnitus therapy devices, etc.) or a device for use by a person with normal hearing (e.g., a consumer device that provides audio streaming, a consumer headphone, an earphone, etc.), a hearing protection device (e.g., a noise cancellation headset, a loudness reduction apparatus, etc.), etc.SUMMARY
[0004] In one aspect, a method is provided. The method comprises: obtaining objective measurement data associated with a recipient of a recipient stimulation device; performing an intensity scaling test during which stimulation is delivered to the recipient via the recipient stimulation device; and controlling the intensity scaling test based on the objective measurement data.
[0005] In another aspect, a method is provided. The method comprises: obtaining historical intensity scaling test data associated with a recipient of a recipient stimulation device;Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1determining one or more intensity scaling test parameters based on the historical intensity scaling test data; using the one or more intensity scaling test parameters to administer an intensity scaling test to the recipient via the recipient stimulation device; and determining one or more operational settings for the recipient stimulation device based on an outcome of the intensity scaling test
[0006] In another aspect, a method is provided. The method comprises: obtaining at least one amplitude growth function (AGF) derived from evoked compound action potential measurements of a region of a recipient of a recipient stimulation device; performing a loudness scaling test during which sounds are delivered to the region of the recipient as electrical stimulation; and controlling the loudness scaling test based on the at least one amplitude growth function.
[0007] In another aspect, one or more non-transitory computer readable storage media are provided. The one or more non-transitory computer readable storage media comprise instructions that, when executed by one or more processors, cause the one or more processors to: obtain objective measurement data associated with a recipient; determine one or more intensity scaling test parameters based on the objective measurement data; deliver, via a recipient stimulation device, first stimulation to the recipient; provide the recipient with a set of response options for rating a perceived relative intensity of the first stimulation; receiving, via the set of response options, an indication of the recipient’s perceived intensity of the first stimulation; determine, using active learning, second stimulation for delivery to the recipient; and deliver, via the recipient stimulation device, the second stimulation to recipient.BRIEF DESCRIPTION OF THE DRAWINGS
[0008] Embodiments of the present invention are described herein in conjunction with the accompanying drawings, in which:
[0009] FIG. 1 is a schematic diagram illustrating an example recipient stimulation device fitting system that includes a recipient stimulation device that can benefit from the use of certain techniques presented herein;[ooto] FIG. 2A is a graph illustrating a plurality of evoked compound action potential (ECAP) responses as a function of time;
[0011] FIG. 2B is a graph illustrating an example amplitude growth function (AGF) determined from the plurality of ECAP responses of FIG. 2A;Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1
[0012] FIG. 3 is a flowchart of a method for using at least one AGF to control a loudness scaling test, in accordance with certain embodiments presented herein;
[0013] FIG. 4 is an example flowchart illustrating an example method, in accordance with certain embodiments presented herein;
[0014] FIG. 5A is an example flowchart illustrating another example method, in accordance with certain embodiments presented herein;
[0015] FIG. 5B is an example flowchart illustrating another example method, in accordance with certain embodiments presented herein;
[0016] FIG. 6 is a functional block diagram of an implantable stimulator system that is configured to operate using one or more operational settings determined using an intensity scaling test that is controlled in accordance with aspects presented herein;
[0017] FIG. 7 illustrates an example cochlear implant system that is configured to operate using one or more operational settings determined using an intensity scaling test that is controlled in accordance with aspects presented herein;
[0018] FIG. 8 illustrates a retinal prosthesis system that is configured to operate using one or more operational settings determined using an intensity scaling test that is controlled in accordance with aspects presented herein;
[0019] FIG. 9 is a schematic diagram illustrating a vestibular stimulator system that is configured to operate using one or more operational settings determined using an intensity scaling test that is controlled in accordance with aspects presented herein;
[0020] FIG. 10 is a perspective view of an upper airway stimulation device that is configured to operate using one or more operational settings determined using an intensity scaling test that is controlled in accordance with aspects presented herein;
[0021] FIG. 11 is a schematic diagram illustrating a tinnitus therapy device that is configured to operate using one or more operational settings determined using an intensity scaling test that is controlled in accordance with aspects presented herein; and
[0022] FIG. 12 illustrates an example of a suitable computing system with which one or more of the disclosed examples can be implemented.Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1DETAILED DESCRIPTION
[0023] Presented herein are techniques for controlling an intensity (e.g., loudness) scaling test administered to a recipient of a recipient stimulation device, and using one or more results / outcomes of the intensity scaling test to determine / set one or more operational settings / parameters of the recipient stimulation device. That is, one or more outcomes of the intensity scaling test, referred to herein as “intensity scaling test data,” are used to program one or more operational settings of the recipient stimulation device for use in delivering subsequent stimulation to the recipient. The presented techniques can, for example, improve time efficiency, reliability, and / or comfort of intensity scaling / testing. By leveraging objective measurement data and active learning, the techniques can reduce the need for extensive manual adjustments and subjective assessments, leading to quicker and more accurate test results. Additionally, the ability to adapt stimulation parameters based on recipient feedback can ensure more comfortable experience and optimal settings for the recipient.
[0024] In particular, in certain embodiments presented herein, one or more aspects / parameters of an intensity scaling test, sometimes referred to herein as “intensity scaling test parameters,” are controlled (e.g., set, determined, etc.) based on objective measurement data derived from one or more objective measurements. The objective measurement data can comprise, for example, at least one amplitude growth function (AGF) derived from electrically evoked compound action potentials (eCAPs) captured from the recipient or data derived from electrically evoked stapedius reflex thresholds (eSRTs) captured from the recipient. In certain examples presented herein, one or more intensity scaling test parameters are controlled based on historical intensity scaling test data (e.g., intensity scaling test data obtained from one or more prior intensity scaling tests). In certain embodiments presented herein, active learning is used to control one or more intensity scaling test parameters.
[0025] There are a number of different types of devices in / with which the techniques presented herein can be implemented. Merely for ease of description, the techniques presented herein are primarily described with reference to a specific type of device, namely recipient stimulation devices. However, it is to be appreciated that the techniques presented herein can also be partially or fully implemented by any of a number of different types of devices or systems, including consumer electronic devices (e.g., consumer hearing devices, consumer computing devices such as mobile phones and tablets, audio equipment such as home theatre and car audio systems, etc.), computing systems (e.g., servers in data centers, Intemet-of-Things (loT) devices), various types of software systems, such as databases, machine learning and artificialAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1intelligence systems, other medical devices, such as diagnostic equipment or life sustaining equipment, etc. For example, the techniques presented herein could be used in or with sensory protheses, including hearing aids and cochlear implants, and various medical devices, such as pacemakers, drug delivery systems, implantable defibrillators, functional electrical stimulation devices, sleep disorder devices (e.g., sleep apnea devices), seizure devices (e.g., devices for monitoring and / or treating epileptic events), balance or movement disorder devices (e.g., vestibular stimulation devices), tinnitus management devices, visual implants (e.g., bionic eyes), and other neuromodulation devices (e.g., brain-computer interfaces).
[0026] FIG. 1 illustrates an example recipient stimulation device fitting system (fitting system) 100 that includes a recipient stimulation device 110 that can benefit from the use of technologies described herein. As used herein, a “recipient stimulation device” is an externally worn or implantable device (potentially as part of a system of devices / components) that generates and delivers stimulation signals (stimulation) to a recipient (user). The stimulation can comprise, for example, acoustic stimulation, mechanical stimulation, electrical stimulation, optical stimulation, etc.
[0027] In the illustrative example of FIG. 1, the fitting system 100 includes a recipient computing device 120, a clinician computing device 130, and a fitting server 140, which are connected with one another over a network 102. The network 102 can be, for example, a wired or wireless computer network (e.g., Local Area Network (LAN), Metropolitan Area Network (MAN), Wide Area Network (WAN), etc.), which facilitates the communication of data among the computing devices connected to the network.
[0028] As illustrated, the recipient stimulation device 110 and the recipient computing device 120 are operated by the recipient (user) in an environment 101. The environment 101 defines the conditions in which the recipient stimulation device 110 and the recipient computing device 120 operate. In certain examples herein, the environment 101 includes the auditory conditions in which the recipient stimulation device 110 functions. Such auditory conditions can include, for example, a loudness of noise in the environment (e.g., whether the environment 101 is loud or quiet). Other examples relate to the visual environment in which the recipient stimulation device 110 functions. Such visual conditions can include, for example, brightness or colors of the environment.
[0029] As noted, the recipient stimulation device 110 is a device / apparatus that is configured to generate and deliver stimulation to the recipient. In certain examples, the recipientAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1stimulation device 110 is configured to generate and deliver stimulation to the recipient based on one or more input signals (e.g., motion signals, measurement signals, spatial / environmental signals, etc.). In addition, in certain examples, the recipient stimulation device 110 generates and delivers the stimulation to the recipient using one or more operational settings that are specific for the recipient. That is, the recipient stimulation device 110 is fitted or customized to conform to the specific physiology of that recipient. This procedure, which sometimes referred to as “programming,” “mapping” or “fitting” (“fitting” herein), results in a collection of recipient-specific operational settings / parameters that are sometimes collectively referred to as the device or recipient a “program” or “map” (“map” herein). In certain examples, the recipient map includes lower limits of stimulation intensity, sometimes referred threshold levels (T-levels), and / or upper limits of stimulation intensity, sometimes referred to as comfort levels (C-levels), for each stimulation channel (e.g., an electrode or collection of electrodes). In some examples, implementation of the map ensures that the stimulation provides a recipient with comfortable and accurate perception, enabling the recipient to receive maximum benefit from the device.
[0030] In an example, the recipient stimulation device 110 is a hearing device, such as a hearing aid, cochlear implant, bone conduction device (e.g., percutaneous bone conduction device, transcutaneous bone conduction device, active bone conduction device, passive bone conduction device, etc.), or a middle ear auditory prosthesis, among others. However, the recipient stimulation device 110 can take any of a variety of forms and examples are such forms are described in more detail in FIGs. 6-11.
[0031] In embodiments in which the recipient stimulation device 110 is a hearing device, the recipient stimulation device 110 can be configured to provide stimulation to a user to cause auditory percepts based on a current map 115 and audio detected in the environment 101. Where the recipient stimulation device is a visual prosthesis, the recipient stimulation device 110 can be configured to provide stimulation to a user to cause visual percepts based on a current map 115 and light detected in the environment 101.
[0032] Returning to the example of FIG. 1, the recipient stimulation device 110 includes a memory 113, one or more processors 116, and a stimulator 145, among other components. In the illustrated example, the memory 113 stores a log 112 and one or more maps 114. The log 112 is a set of one or more data structures that are records of data, activity, or events relevant to the recipient stimulation device 110. In an example, the log 112 includes data regardingAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1multiple fitting sessions. The one or more data structures of the log can be implemented in any of a variety of ways.
[0033] As noted, the maps 114 each include one or more operational settings for the recipient stimulation device 110. In an example, the one or more maps 114 describes an allocation of frequencies from a filter bank or other frequency analyzer to individual electrodes of the stimulator 145. In an example, the one or more maps 114 describe electrical maps from sound levels in one or more or all of the frequency bands to electrical stimulation levels. The one or more maps 114 can be performed on a one-to-one basis, with each filter output is allocated to a single electrode. The one or more maps 114 can be created based on operational settings, such as threshold levels (T levels) and maximum comfort levels (C levels) for one or more or all stimulation channels of the recipient stimulation device 110. In an example, the one or more maps 114 are stored by programming the recipient stimulation device 110 or by any other process that sets the channels of the recipient stimulation device 110 to have the map 114.
[0034] The maps 114 can each be or include one or more operational settings having values that affect how the recipient stimulation device 110 operates. For instance, the maps 114 can include a map 114 having minimum and maximum stimulation levels for frequency bands of stimulation channels. The map 114 is then used by the recipient stimulation device 110 to control an amount of stimulation to be provided. For instance, where the recipient stimulation device 110 is a cochlear implant, the map 114 affects which electrodes of the cochlear implant to stimulate and in what amount based on a received sound input. In some examples, the maps 114 include two or more predefined groupings of operational settings selectable by the user. One of the two or more predefined groupings of operational settings can be a default group. In an example, the maps 114 can be ordered, such as based on relative loudness of the maps. For example, a first map 114 can have a lower loudness than an wth map 114, where n is the highest numbered map 114. In some examples, the differences between the maps 114 are simply intensity of stimulation. In other examples, there can be other differences between maps 114. In some implementations, the maps 114 can have different shapes compared to one another. For instance, the maps can be based on principle component analysis.
[0035] The maps 114 can also include sound processing settings that modify sound input before it is converted into a stimulation signal. Such settings can include, for example, particular audio equalizer settings can boost or cut the intensity of sound at various frequencies. In examples, the maps 114 can include a minimum threshold for which received sound input causes stimulation, a maximum threshold for preventing stimulation above a level which wouldAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1cause discomfort, gain parameters, loudness parameters, and compression parameters. The maps 114 can include settings that affect a dynamic range of stimulation produced by the recipient stimulation device 110. As described above, many ofthe maps 114 affect the physical operation of the recipient stimulation device 110, such as how the recipient stimulation device 110 provides stimulation to the user in response to sound input received from the environment 101.
[0036] The one or more processors 116 include one or more hardware or software processors (e.g., microprocessors or central processing units). In many examples, the one or more processors 116 are configured to obtain and execute instructions from the memory 113.
[0037] The stimulator 145 includes the stimulation generation and delivery components as well as additional support components of the recipient stimulation device 110. Examples include an electronics module and stimulation assembly, such as stimulation assemblies described in more detail below. As a specific example, the stimulator 145 is or includes an auditory stimulator. The auditory stimulator can be a component configured to provide stimulation to a user’s auditory system to cause a hearing percept to be experienced by the user. Examples of components usable for auditory stimulation include components for generating airconducted vibrations, components for generating bone -conducted vibration, components for generating electrical stimulation, other components, or combinations thereof.
[0038] The recipient computing device 120 is a computing device associated with the user of the recipient stimulation device 110. In many examples, the recipient computing device 120 is a mobile phone, tablet computer, laptop computer, smart watch, etc., but can take other forms. As illustrated, the recipient computing device 120 includes memory 123 and one or more processors 126.
[0039] As illustrated, the memory 123 includes fitting instructions 122. The fitting instructions 122 can be instructions executable by the one or more processors 126 of the recipient computing device 120 to implement one or more methods or operations described herein. In some examples, the fitting instructions 122 are a part of instructions executable to provide a recipient stimulation device application 124. In some examples, the memory 123 also stores the log 112 and one or more maps 114.
[0040] In examples, the recipient computing device 120 includes or implements the recipient stimulation device application 124 that operates on the recipient computing device 120 and cooperates with the recipient stimulation device 110. For instance, the recipient stimulationAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1device application 124 can control the recipient stimulation device 110 (e.g., based on input received from the user) and obtain data from the recipient stimulation device 110. The recipient computing device 120 can connect to the recipient stimulation device 110 using, for example, a wireless radio frequency communication protocol (e.g., Wi-Fi, Bluetooth, Bluetooth Low Energy (BLE), ultra-wideband (UWB), etc.)). The recipient stimulation device application 124 transmits or receives data from the recipient stimulation device 110 over such a connection. The recipient stimulation device application 124 can also stream audio to the recipient stimulation device 110, such as from a microphone of the recipient computing device 120 or an application running on the recipient computing device 120 (e.g., a video or audio application).
[0041] In some examples, the recipient stimulation device application 124 provides a fitting user interface, shown as interface 150 in FIG. 1. As described further below, the fitting user interface 150 is configured to obtain fitting information from the user. As illustrated, the fitting user interface 150 includes a query 151 to the user in the form of a text prompt along a set of response options 175. More specifically, in this example, the set of response options 175 are formed by five user interface elements (e.g., buttons) that comprise a first user interface element 152 selectable to indicate that the stimulation is too loud (too high), a second user interface element 156 selectable to indicate that the stimulation is a little loud (little too high), a third user interface element 157 selectable to indicate that the stimulation is just right, a fourth user interface element 158 selectable to indicate that the stimulation is a little soft (a little too low), and a fifth user interface element 159 selectable to indicate that the stimulation is too soft (too low). Other implementations of a user interfaces 150 can be provided in alternative arrangements.
[0042] The clinician computing device 130 is a computing device used by a medical practitioner / professional that provides care or supervision for the recipient, such as a clinician, audiologist, etc. The clinician computing device 130 includes one or more software programs usable to monitor the recipient stimulation device 110, such as fitting progress thereof. The clinician computing device 130 can include memory 133 and one or more processors 136. In an example, the memory 133 stores instructions that, when executed by the one or more processors 136 causes the one or more processors 136 to obtain data regarding fitting of the recipient stimulation device 110 (e.g., via the server 140 or by a direct connection between the recipient stimulation device 110 or the recipient computing device 120 and the clinicianAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1computing device 130) and present such data to the clinician over a clinician user interface. In some examples, the data includes data stored in the log 112.
[0043] The fitting server 140 is a server computing device remote from the recipient stimulation device 110, recipient computing device 120, and the clinician computing device 130. The fitting server 140 is communicatively coupled to the recipient computing device 120 and the clinician computing device 130. In many examples, the fitting server 140 is indirectly communicatively coupled to the recipient stimulation device 110 through the recipient computing device 120 (e.g., via the recipient stimulation device application 124). In some examples, the fitting server 140 is directly communicatively coupled to the recipient stimulation device 110. The fitting server 140 includes memory 143, one or more processors 146, and fitting software 142. The fitting software 142 is software operable to perform one or more operations described herein, such as operations that fit the recipient stimulation device 110. The fitting software 142 can customize the recipient stimulation device 110 based on feedback from the user or the clinician.
[0044] In the examples of FIG. 1, the memory 113, 123, 133, and 143 can each comprise one or more software-based or hardware-based computer-readable storage media operable to store information accessible by the one or more processors 116, 126, 136, and 146, respectively. The memory 113, 123, 133, and 143 can each comprise comprise / include RAM, ROM, EEPROM (Electronically-Erasable Programmable Read-Only Memory), flash memory, optical disc storage, magnetic storage, solid state storage, or any other memory media usable to store information for later access. In examples, the memory 113, 123, 133, and 143 can each encompass a modulated data signal (e.g., a signal that has one or more of its characteristics set or changed in such a manner as to encode information in the signal), such as a carrier wave or other transport mechanism and includes any information delivery media. By way of example, and not limitation, the memory 113, 123, 133, and 143 can each include wired media such as a wired network or direct-wired connection, and wireless media such as acoustic, RF, infrared and other wireless media or combinations thereof.
[0045] The components of the recipient stimulation device fitting system 100 can cooperate to perform one or more of the techniques presented herein. For example, in accordance embodiments presented herein, the recipient stimulation device 110 can be used in an enhanced intensity (e.g., loudness) scaling testing for determining (e.g., setting, adjusting, etc.) one more operational settings / parameters of the recipient stimulation device 110 (e.g., settings within maps 114). The enhanced intensity scaling testing for can be used to, for example, determineAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1the threshold levels (T levels) and maximum comfort levels (C levels) for one or more or all stimulation channels of the recipient stimulation device 110. The enhanced intensity scaling testing can be used to determine, for example, a loudness growth functions (Q level) for one or more or all stimulation channels of the recipient stimulation device 110, as the loudness growth function controls how the dynamic range of an input signal is translated to an electrical output. In certain embodiments, enhanced intensity scaling testing can be used to set or control, for example, target gain(s), maximum power output (MPO), gain curves / kneepoints, etc. Once determined, the one or more operational settings determined using a loudness scaling test can be instantiated (e.g., installed in) the recipient stimulation device.
[0046] As used herein, an intensity scaling test is a type of test in which one or more stimulation signals are delivered to a user via a recipient stimulation device used by (e.g., worn by or implanted in) the user. During the intensity scaling test, the user is instructed (e.g., verbally, visually, etc.) to provide an indication of a perceived intensity / loudness of the one or more stimulation signals when delivered to the user via the recipient stimulation device.
[0047] In the specific context of a hearing device, an intensity scaling test is referred to as a “loudness scaling test,” and is a type of audiological test in which stimulation signals representative of sounds (e.g., one or more tones) are delivered to at least one ear of the user via the hearing device used by (e.g., worn by or implanted in) the user. That is, the hearing device is used to evoke a hearing percept at one or more ears of the user. During the loudness scaling test, the user is instructed (e.g., verbally, visually, etc.) to provide an indication of a perceived loudness of the stimulations, when delivered to the user via the hearing device. During a loudness scaling test, the sounds can be generated by the hearing device, captured by the sound inputs (e.g., microphones of the hearing device), received from an external computing device (e.g., streamed via Bluetooth, via a connected cable, etc.), etc.
[0048] For ease of illustration, aspects of the techniques presented herein are primarily described further below with reference to loudness scaling tests for a cochlear implant. However, it is to be appreciated that specific reference to loudness scaling tests and / or cochlear implants is merely illustrative and that the techniques presented herein can be used with other types of intensity scaling tests and / or with other types of recipient stimulation devices.
[0049] One type of loudness scaling test used with hearing devices, such as cochlear implants, is the Adaptive Categorical Loudness Scaling (ACALOS) test / procedure. The ACALOS test is used to measure and quantify the recipient's perception of loudness in a systematic way. ThisAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1test is particularly important in fitting hearing aids and cochlear implants, where it is crucial to understand the individual loudness perception of recipients to provide optimal auditory support.
[0050] In a typical ACALOS test, sounds of varying intensities are delivered / presented to the recipient in the form of stimulation. For cochlear implant recipients, electrical (current) pulses at different amplitudes are delivered. The recipient then rates (e.g., using interface 150 of FIG.1) the perceived loudness of each sound / stimulus using a predefined categorical scale (e.g., very soft, soft, medium, loud, very loud). The test adapts based on the recipient's subjective feedback / responses, adjusting the intensity of subsequent stimuli to adapt to the levels that accurately map to the loudness categories.
[0051] However, there are several issues with a conventional ACALOS test / procedure that limit its effectiveness and reliability. First, the ACALOS procedure typically has a long duration. The total test time for an ACALOS procedure can vary depending on the participant's responses and the specific protocol used, but it generally takes around 20 to 30 minutes (mean 25 minutes) to set the loudness for only 5 stimulation channels, which is one of the reasons it is not widely used in fitting practices. Second, at least partially due to the long duration, recipients can experience fatigue during the test, leading to inconsistent responses. Response bias, where participants might unintentionally or intentionally provide skewed responses, can also impact the results. Furthermore, responses can be impacted by history of responses (previous stimulation weather too soft or too loud).
[0052] Third, external noise and variations in testing environments can affect the accuracy of the test. Ensuring a consistent and quiet environment is challenging but essential for reliable results. Fourth, the ACALOS procedure relies on subjective responses from participants to categorize loudness, which can vary significantly between individuals due to personal perception differences and interpretation of loudness categories. Fifth, the ACALOS procedure typically covers a limited frequency range (uses a specific set of frequencies). This limited range might not fully represent an individual's loudness perception across the entire audible spectrum, potentially overlooking critical areas of hearing sensitivity. Sixth, the accuracy of the ACALOS procedure heavily depends on the proper calibration and maintenance of audiological equipment. Inconsistent calibration can lead to erroneous loudness scaling results. Seventh, there is a lack of standardized interpretation of results across different audiologists and clinics. This can lead to variability in how the ACALOS procedure are used to fit hearing devices or diagnose hearing issues.Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1
[0053] As noted above, presented herein are enhancements / improvements for an intensity scaling test procedure (e.g., enhanced ACALOS test) that address some of the issues with conventional intensity tests. Also as noted, various aspects of the enhanced intensity scaling testing are described further below, again with specific reference to loudness scaling tests and cochlear implants.
[0054] More specifically, in accordance with certain embodiments presented herein, a loudness scaling test can be at least partially controlled by (e.g., performed based on) one or more objective measurements obtained / captured from the recipient. In one example, the objective measurements include at least one amplitude growth function (AGF) derived from evoked compound action potential (ECAP) measurements obtained from the recipient. In such embodiments, an objective AGF derived from the EACPs can be used to determine electrical stimulation levels (current levels) for use during the loudness scaling test. In certain examples, the determination of the electrical stimulation levels involves use of AGF population statistics together with measured loudness scaling data. This approach can, for example, remediate the subjective nature of the test, reduce measurement time, response bias / fatigue, and / or eliminates the need for the boundary finding phase in the ACALOS procedure.
[0055] FIG. 2A is a graph illustrating a plurality of ECAP responses 260 as a function of time, while FIG. 2B illustrates an example amplitude growth function (AGF) 262, determined from the plurality of ECAP responses 260, also shown as a function of time (e.g., a graph of ECAP amplitude to different stimulus levels as a function of time). The AGF 262 includes a number of different attributes and, in certain examples presented herein, the attributes of the AGF 260, such as noise floor level, AGF slope, maximal amplitude, etc. can be used to control one or more intensity (loudness) scaling test parameters (e.g., device parameters or other settings used during a loudness scaling test). For example, these attributes could be used to determine the stimulus levels used during the loudness scaling test, determine stimulus level changes during the loudness scaling test, etc.
[0056] FIG. 3 is a flowchart of a method 370 for using at least one amplitude growth function (AGF) in a cochlear implant recipient loudness scaling test, in accordance with certain embodiments presented herein. Method 370 begins at 372 where a system obtains at least one AGF associated with the recipient. The AGF is derived from evoked compound action potential (ECAP) measurements captured from the recipient (e.g., captured from a region of the recipient, such as the inner ear of the recipient).Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1
[0057] At 374, a fitting system performs a loudness scaling test during which sounds are delivered to the inner ear of the recipient as electrical stimulation. At 376, the loudness scaling test is controlled based on the at least one AGF. That is, one or more attributes of the at least one AGF are used to control (e.g., determine, set, adjust, change, etc.) one or more parameters of the loudness scaling test. As noted elsewhere herein, an outcome of the loudness scaling test can be used to determine one or more operational settings for the recipient stimulation device that can, accordingly, be instantiated in the recipient stimulation device for use in delivering subsequent stimulation to the recipient.
[0058] It is to be appreciated that the loudness scaling test can be controlled based on the at least one AGF in a number of different manners. For example, in certain arrangements, an initial intensity (amplitude) of the electrical stimulation delivered to the inner ear during the loudness scaling test can be controlled (e.g., set) based on the at least one AGF. In certain arrangements, the at least one AGF can be used to control how the intensity of the electrical stimulation delivered to the recipient is adapted during the loudness scaling test. In certain arrangements, the at least one AGF and subjective feedback from the recipient are collectively used to control how the intensity of the electrical stimulation delivered to the recipient is adapted during the loudness scaling test. The at least one AGF, potentially in combination with the subjective feedback, can be used to adapt a rate of change of the intensity, or a step size change in the intensity of the electrical stimulation, delivered to the inner ear.
[0059] As noted above, various attributes of the at least one AGF can be used to control a loudness scaling test in accordance with embodiments presented herein. In certain examples, a slope of the at least one AGF is used to control a parameter of the loudness scaling test. In other examples, AGF attributes such as noise floor level, maximal amplitude, etc. can be used to control one or more intensity (loudness) scaling test parameters.
[0060] In certain examples, controlling the loudness scaling test based on the at least one AGF includes using the at least one AGF to determine a predicted loudness growth function for a first electrode. The loudness scaling test is then performed / implemented to validate (or invalidate) the predicted loudness growth function.
[0061] In certain examples, performing the loudness scaling test includes delivering a first stimulation to the inner ear via a first electrode, providing the recipient with a set of response options for rating a perceived relative loudness of the first stimulation, and receiving, via the set of response options, an indication of the recipient’s perceived loudness of the firstAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1stimulation. The recipient’s indication of perceived loudness, potentially in combination with the at least one AGF can be used to control delivery of second stimulation to the inner ear via the first electrode.
[0062] As noted, FIGs. 2A, 2B, and 3 illustrate examples in which at least one AGF is used to control a loudness scaling test. In accordance with embodiments presented herein, other objective measurement data could be used to control one or more intensity (loudness) scaling test parameters. For example, in some embodiments, the objective measurement data can comprise data derived from electrically evoked stapedius reflex thresholds (eSRTs) captured from the recipient.
[0063] As noted, FIGs. 2A, 2B, and 3 illustrate examples in which at objective measurements are used to control a loudness scaling test. In accordance with embodiments presented herein, other techniques, potentially in combination with an objective measurement (e.g., AGF), can be used to control one or more intensity (loudness) scaling test parameters.
[0064] For example, in certain embodiments, the techniques presented herein can use historical intensity (loudness) scaling data from a prior (e.g., most recent) intensity scaling test to control one or more intensity scaling test parameters. In certain embodiments, historical intensity scaling data can be data obtained from the target electrode (the electrode to be tested) and / or data obtained from other electrodes (e.g., a neighboring electrode to the target electrode). For example, the historical intensity scaling data, which was obtained during a prior loudness scaling test, could be used to set the initial stimulation levels and / or to minimize uncertainty around T-levels and optimal C-Levels.
[0065] In certain embodiments, active learning based on AGF data and / or collected responses is used to reduce measurement time and improve accuracy. That is, in these examples, active learning is used to dynamically adjust the loudness scaling test parameters, in real-time, to reduce the overall measurement time while enhancing the accuracy of the loudness scaling test.
[0066] For example, in accordance with certain embodiments presented herein, a loudness scaling test is an adaptive procedure that depends on AGF attributes (e.g., AGF slope, population statistics of maximal amplitude, noise floor, etc.), historical responses (previous test results), and recipient feedback. These different factors can be used in an active learning function to minimize an error (e.g., root mean square (RMS) error) and update the fitting function parameters and next optimal stimulus levels based on maximal stimulus level distance in the dynamic range. This approach ensures that the fitting function parameters and optimalAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1stimulus levels are continuously refined and updated, leading to more precise and individualized loudness scaling results
[0067] The techniques presented herein can also provide active learning termination conditions for a loudness scaling test. The active learning termination conditions can be based, for example, on root mean square (RMS) error, Mean Absolute Error (MAE), minimum number of responses, or other factors. This ensures that the test ends only when reliable and accurate data has been obtained. For example, in certain arrangements, a loudness scaling test is terminated when:• The RMS error falls below a specified threshold, and a minimum number of responses (x responses) have been collected (ensuring some loudness category values), or • The maximum allowable number of samples has been obtained, and the error remains below the predefined maximal allowed error threshold.
[0068] FIG. 4 is an example flowchart illustrating an example method 470, in accordance with certain embodiments presented herein. In this example, the method 470 begins at 472 where a system (e.g., fitting system, computing device, etc.) determines the initial (N) stimulation levels (e.g., amplitudes) for a loudness scaling test for atarget electrode. The initial stimulation levels can be determined using objective measurement data (e.g., AGF function parameters) obtained at 469 (e.g., AGF function parameters, such as slope, noise floor, maximal amplitude, etc., from previous / recent ECAP measurements) and / or based on historical intensity scaling data obtained at 471 (e.g., data from a previous loudness scaling test associated with the target electrode, loudness scaling test associated with a neighboring electrode, etc., used to find the logistic / exponential function parameters).
[0069] At 474, the loudness scaling test is initiated and stimulation is delivered / presented to the recipient using the initial stimulation levels. In addition, subjective feedback (e.g., recipient responses) related to the delivered stimulation is obtained. The subjective feedback can, for example, provide an indication of the recipient’s perceived loudness of the stimulation (e.g., provide the recipient with a set of response options for rating a perceived relative loudness of the stimulation and receive, via the set of response options, an indication of the recipient’s perceived loudness of the stimulation).
[0070] At 476, the system determines whether one or more predetermined termination conditions (e.g., based on RMS or Mean Absolute Error (MAE) and minimum number ofAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1responses) have been satisfied. If the one or more predetermined termination conditions have been satisfied, then method 470 ends. However, if the one or more predetermined termination conditions have not been satisfied, then method 470 proceeds to 478 where an optimization function / machine-leaming techniques (e.g., active learning or Bayesian inference) are used to update prior believes (e.g., prior stimulation levels) using new available data to determine new stimulation levels (next stimulus levels). The optimization function could, for example, minimizes the RMS error using the new available data.
[0071] After the new stimulation levels are determined, the method 470 returns to 474 where the new stimulation levels are used to continue the loudness scaling test (e.g., stimulation is delivered to the recipient using the new stimulation levels and an indication of the recipient’s perceived loudness of the stimulation is received). The operations of 474, 476, and 478 are repeated until the one or more predetermined termination conditions are satisfied.
[0072] FIG. 5A is a flowchart illustrating an example method 570, in accordance with certain embodiments presented herein. Method 570 begins at 572 where a system obtains objective measurement data associated with a recipient of a recipient stimulation device. The objective measurement data can comprise, for example, at least one amplitude growth function (AGF) derived from electrically evoked compound action potentials (eCAPs) captured from the recipient or data derived from electrically evoked stapedius reflex thresholds (eSRTs) captured from the recipient. At 574, the system performs / executes an intensity scaling test during which stimulation is delivered to the recipient via the recipient stimulation device. At 576, the intensity scaling test is controlled based on the objective measurement data. For example, one or more aspects / parameters of the intensity scaling test (the loudness scaling test parameters) are set, determined, adapted / adjusted, etc., based on the objective measurement data.
[0073] FIG. 5B is a flowchart illustrating an example method 580, in accordance with certain embodiments presented herein. Method 580 begins at 582 where a system obtains historical intensity scaling test data associated with a recipient of a recipient stimulation device. At 584, the system determines one or more intensity scaling test parameters based on the historical intensity scaling test data. At 586, the system uses the one or more intensity scaling test parameters to administer an intensity scaling test to the recipient via the recipient stimulation device. At 588, the system determines one or more operational settings for the recipient stimulation device based on an outcome of the intensity scaling test.
[0074] As noted above, certain aspects presented herein provide for objective determination ofAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1loudness scaling test parameters, such as stimulation levels, thereby reducing subjectivity in a loudness scaling test. For example, by utilizing the objective Amplitude Growth Function (AGF) derived from evoked compound action potentials (EACP), the procedure minimizes the subjective nature of test measurements. This leads to more reliable and consistent results. In addition, the need for the boundary-finding phase in the ACALOS procedure is removed, streamlining the process.
[0075] In addition, certain aspects presented herein enhance the efficiency and speed of a loudness scaling test. In particular, the use of historical data and active learning methods reduces the time required to conduct the loudness scaling test. In addition, leveraging historical intensity scaling data from previous sessions or neighboring electrodes allows for quicker and more accurate initial stimulation levels. Utilizing data from previous sessions ensures consistency in stimulation levels across multiple tests, leading to more reliable long-term tracking of auditory function.
[0076] Moreover, certain aspects presented herein provide enhanced precision and minimize response bias and fatigue. For example, active learning and the fitting of objective functions (logistic or exponential) based on AGF data enable accurate identification of optimal stimulation levels. The objective nature of the procedure reduces the potential for response bias and fatigue, leading to more accurate measurements.
[0077] Certain aspects presented herein also enable the loudness scaling test to be adaptable. For example, the adaptive procedure can factor in AGF slope, population statistics, noise floor, historical responses, and recipient feedback to continuously refine and update fitting function parameters and optimal stimulus levels. That is, the loudness scaling test is dynamically adjusted. In addition, by incorporating recipient feedback and historical responses, the procedure can tailor itself to individual needs, enhancing overall effectiveness. The combination of AGF data and active learning helps identify and mitigate issues related to long T-tails, which can otherwise complicate the measurement process.
[0078] Also, as noted above, certain aspects presented herein provide clear termination conditions for a loudness scaling test via defined endpoints and controlled sample size. In particular, the procedure includes specific termination conditions, such as achieving an RMS error below a threshold and collecting a minimum number of responses, ensuring that the test ends only when reliable data has been obtained. In addition, the procedure caps the maximum number of samples, maintaining efficiency while ensuring accuracy is not compromised.Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1
[0079] In summary, the techniques presented herein can be used to enhances the standard categorical loudness scaling test by increasing objectivity, reducing time and effort, improving accuracy, and providing a more tailored and adaptive approach to determining optimal stimulus levels.
[0080] In certain examples, the techniques presented herein can also or alternatively serve as a quality check for the current fitting of the stimulation device. By validating the predicted loudness growth functions based on test outcomes, the methods can raise an alarm to adjust the settings either automatically or may require an approval step from clinician or user. This ensures that the device is correctly fitted and functioning optimally for the recipient.
[0081] As noted above, the techniques disclosed herein can be applied in any of a variety of circumstances and with a variety of different recipient stimulation devices. For example, the recipient stimulation device can take the form of a variety of different consumer devices or medical devices. Example consumer devices include headphones, earbuds, personal sound amplification products, wireless earbuds, or other consumer devices. Example medical devices (or systems) include, for example, hearing / auditory protheses, vestibular stimulators, retinal prostheses, tinnitus therapy devices, upper airway stimulation devices, neurostimulators, cardiac pacemakers, cardiac defibrillators, seizure therapy stimulators, as well as other medical devices that deliver stimulation to a recipient tissue. Specific example devices that can benefit from technology disclosed herein are described in more detail in FIGs. 6-11, below. For example, the techniques described herein can be used to with different medical devices, such as an implantable stimulation system as shown FIG. 6, a cochlear implant as shown in FIG. 7, a retinal prosthesis as shown in FIG. 8, a vestibular stimulator as shown in FIG. 9, an upper airway stimulation device as shown in FIG. 10, and a tinnitus therapy device as shown in FIG.11.
[0082] More specifically, FIG. 6 is a functional block diagram of an implantable stimulator system 600 that can benefit from the technologies described herein. In an example, the recipient stimulation device 110 corresponds to the implantable stimulator system 600. The implantable stimulator system 600 includes a wearable device 610 acting as an external processor device and an implantable device 650 acting as an implanted stimulator device. In examples, the implantable device 650 is an implantable stimulator device configured to be implanted beneath a user’s tissue (e.g., skin). In examples, the implantable device 650 includes a biocompatible implantable housing 602. Here, the wearable device 610 is configured toAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1transcutaneously couple with the implantable device 650 via a wireless connection to provide additional functionality to the implantable device 650.
[0083] In the illustrated example, the wearable device 610 includes one or more sensors 620, a memory 613, at least one processor 616, a transceiver 618, and a power source 648. The one or more sensors 620 can be units configured to produce data based on sensed activities. In an example where the stimulation system 600 is an auditory prosthesis system, the one or more sensors 620 include sound input sensors, such as a microphone. Where the stimulation system 600 is a visual prosthesis system, the one or more sensors 620 can include one or more cameras or other visual sensors. The processor 116 can be a component (e.g., a central processing unit) configured to control stimulation provided by the implantable device 650. The stimulation can be controlled based on data from the sensor 620, a stimulation schedule, or other data. Where the stimulation system 600 is an auditory prosthesis, the processor 116 can be configured to convert sound signals received from the sensor(s) 620 (e.g., acting as a sound input unit) into signals 651. The transceiver 618 is configured to send the signals 651 in the form of power signals, data signals, combinations thereof (e.g., by interleaving the signals), or other signals. The transceiver 618 can also be configured to receive power or data. Stimulation signals can be generated by the processor 116 and transmitted, using the transceiver 618, to the implantable device 650 for use in providing stimulation.
[0084] In the illustrated example, the implantable device 650 includes a transceiver 618, a power source 648, a coil 656, and a stimulator 640 that includes an electronics module 611 and a stimulator assembly 607. The implantable device 650 further includes a hermetically sealed, biocompatible housing enclosing one or more of the components.
[0085] The electronics module 611 can include one or more other components to provide recipient stimulation device functionality. In many examples, the electronics module 611 includes one or more components for receiving a signal (e.g., from one or more of the sensors 620) and converting the signal into the stimulation signal 615. The electronics module 611 can further be or include a stimulator unit. The electronics module 611 can generate or control delivery of the stimulation signals 615 to the stimulator assembly 607. In examples, the electronics module 611 includes one or more processors (e.g., central processing units or microcontrollers) coupled to memory components (e.g., flash memory) storing instructions that when executed cause performance of an operation. In examples, the electronics module 611 generates and monitors parameters associated with generating and delivering the stimulus (e.g., output voltage, output current, or line impedance). In examples, the electronics module 611Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1generates a telemetry signal (e.g., a data signal) that includes telemetry data. The electronics module 611 can send the telemetry signal to the wearable device 610 or store the telemetry signal in memory for later use or retrieval.
[0086] The stimulator assembly 607 can be a component configured to provide stimulation to target tissue. In the illustrated example, the stimulator assembly 607 is an electrode assembly that includes an array of electrode contacts disposed on a lead. The lead can be disposed proximate tissue to be stimulated. Where the system 600 is a cochlear implant system, the stimulator assembly 607 is configured to be inserted into the user’s cochlea. The stimulator assembly 607 can be configured to deliver stimulation signals 615 (e.g., electrical stimulation signals) generated by the electronics module 611 to the cochlea to cause the user to experience a hearing percept. In other examples, the stimulator assembly 607 is a vibratory actuator disposed inside or outside of a housing of the implantable device 650 and configured to generate vibrations. The vibratory actuator receives the stimulation signals 615 and, based thereon, generates a mechanical output force in the form of vibrations. The actuator can deliver the vibrations to the skull of the user in a manner that produces motion or vibration of the user’s skull, thereby causing a hearing percept by activating the hair cells in the user’s cochlea via cochlea fluid motion. The intensity of the stimulation delivered to the target tissue can be determined / set using an intensity scaling test that is implemented and / or controlled as described elsewhere herein.
[0087] The transceivers 618 can be components configured to transcutaneously receive and / or transmit a signal 651 (e.g., a power signal and / or a data signal). The transceiver 618 can be a collection of one or more components that form part of a transcutaneous energy or data transfer system to transfer the signal 651 between the wearable device 610 and the implantable device 650. Various types of signal transfer, such as electromagnetic, capacitive, and inductive transfer, can be used to usably receive or transmit the signal 651. The transceiver 618 can include or be electrically connected to the coil 656.
[0088] The coils 656 can be components configured to receive or transmit a signal 651, typically via an inductive arrangement formed by multiple turns of wire. In examples, in addition to or instead of a coil, other arrangements are used, such as an antenna or capacitive plates. The magnets can be used to align respective coils 656 of the wearable device 610 and the implantable device 650. For example, the coil 656 of the implantable device 650 is disposed in relation to (e.g., in a coaxial relationship) with an implantable magnet set to facilitate orienting the coil 656 in relation to the coil 656 of the wearable device 610 via the force of aAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1magnetic connection. The coil 656 of the wearable device 610 can be disposed in relation to (e.g., in a coaxial relationship) with a magnet set.
[0089] The power source 648 can be one or more components configured to provide operational power to other components. The power source 648 can be or include one or more rechargeable batteries. Power for the batteries can be received from a source and stored in the battery. The power can then be distributed to the other components of the implantable device 650 as needed for operation.
[0090] FIG. 7 illustrates an example cochlear implant system 710 that can benefit from use of the technologies disclosed herein. For example, the cochlear implant system 710 can be used to implement the recipient stimulation device 110. The cochlear implant system 710 includes an implantable component 744 typically having an internal receiver / transceiver unit 732, a stimulator unit 720, and an elongate lead 718. The internal receiver / transceiver unit 732 permits the cochlear implant system 710 to receive signals from and / or transmit signals to an external device 750. The external device 750 can be, for example, an off-the-ear (OTE) sound processor configured to be worn on the head that includes a receiver / transceiver coil 730 and sound processing components. Alternatively, the external device 750 can be just a transmitter / transceiver coil in communication with a behind-the-ear (BTE) sound processor that includes the sound processing components and microphone.
[0091] The implantable component 744 includes an internal coil 736, and preferably, an implanted magnet fixed relative to the internal coil 736. The magnet can be embedded in a pliable silicone or other biocompatible encapsulating material along with the internal coil 736. Signals sent generally correspond to external sound 713. The internal receiver / transceiver unit 732 and the stimulator unit 720 are hermetically sealed within a biocompatible housing, sometimes collectively referred to as a stimulator / receiver unit. Included magnets can facilitate the operational alignment of an external coil 730 and the internal coil 736 (e.g., via a magnetic connection), enabling the internal coil 736 to receive power and stimulation data from the external coil 730. The external coil 730 is contained within an external portion. The elongate lead 718 has a proximal end connected to the stimulator unit 720, and a distal end 746 implanted in a cochlea 740 of the user. The elongate lead 718 extends from stimulator unit 720 to the cochlea 740 through a mastoid bone 719 of the user. The elongate lead 718 is used to provide electrical stimulation to the cochlea 740 based on the stimulation data. The stimulation data can be created based on the external sound 713 using the sound processing components and based on recipient stimulation device settings. In addition, the intensity of the electricalAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1stimulation delivered to the recipient can be determined / set using an intensity scaling test that is implemented and / or controlled as described elsewhere herein.
[0092] In certain examples, the external coil 730 transmits electrical signals (e.g., power and stimulation data) to the internal coil 736 via a radio frequency (RF) link. The internal coil 736 is typically a wire antenna coil having multiple turns of electrically insulated single-strand or multi-strand platinum or gold wire. The electrical insulation of the internal coil 736 can be provided by a flexible silicone molding. Various types of energy transfer, such as infrared (IR), electromagnetic, capacitive and inductive transfer, can be used to transfer the power and / or data from external device to cochlear implant. While the above description has described internal and external coils being formed from insulated wire, in many cases, the internal and / or external coils can be implemented via electrically conductive traces.
[0093] FIG. 8 illustrates a retinal prosthesis system 800 that comprises an external device 810, a retinal prosthesis 801 and a mobile computing device 803. The retinal prosthesis system 800 can correspond to the recipient stimulation device 110. The retinal prosthesis system 800 comprises a processing module 825 and a retinal prosthesis sensor-stimulator 890 is positioned proximate the retina 891 of a user. The external device 810 and the processing module 825 can both include transmission coils 856 aligned via respective magnet sets. Signals 851 can be transmitted using the coils 856.
[0094] In an example, sensory inputs (e.g., photons entering the eye) are absorbed by a microelectronic array of the sensor-stimulator 890 that is hybridized to a glass piece 892 including, for example, an embedded array of microwires. The glass can have a curved surface that conforms to the inner radius of the retina. The sensor-stimulator 890 can include a microelectronic imaging device that can be made of thin silicon containing integrated circuitry that convert the incident photons to an electronic charge.
[0095] The processing module 825 includes an image processor 823 that is in signal communication with the sensor-stimulator 890 via, for example, a lead 888 which extends through surgical incision 889 formed in the eye wall. In other examples, processing module 825 is in wireless communication with the sensor-stimulator 890. The image processor 823 processes the input into the sensor-stimulator 890 and provides control signals back to the sensor-stimulator 890 so the device can provide an output to the optic nerve. That said, in an alternate example, the processing is executed by a component proximate to, or integrated with, the sensor-stimulator 890. The electric charge resulting from the conversion of the incidentAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1photons is converted to a proportional amount of electronic current which is input to a nearby retinal cell layer. The cells fire and a signal is sent to the optic nerve, thus inducing a sight perception. The intensity of the stimulation delivered to the recipient can be determined / set using an intensity scaling test that is implemented and / or controlled as described elsewhere herein.
[0096] The processing module 825 can be implanted in the user and function by communicating with the external device 810, such as a behind-the-ear unit, a pair of eyeglasses, etc. The external device 810 can include an external light / image capture device (e.g., located in / on a behind-the-ear device or a pair of glasses, etc.), while, as noted above, in some examples, the sensor-stimulator 890 captures light / images, which sensor-stimulator is implanted in the user.
[0097] FIG. 9 illustrates an example vestibular stimulator system 902, with which embodiments presented herein can be implemented. As shown, the vestibular stimulator system 902 comprises an implantable component (vestibular stimulator) 912 and an external device / component 904 (e.g., external processing device, battery charger, remote control, etc.). The external device 904 comprises a transceiver unit 960. As such, the external device 904 is configured to transfer data (and potentially power) to the vestibular stimulator 912.
[0098] The vestibular stimulator 912 comprises an implant body (main module) 934, a lead region 936, and a stimulating assembly 916, all configured to be implanted under the skin / tissue (tissue) 915 of the recipient. The implant body 934 generally comprises a hermetically-sealed housing 938 in which RF interface circuitry, one or more rechargeable batteries, one or more processors, and a stimulator unit are disposed. The implant body 934 also includes an intemal / implantable coil 914 that is generally external to the housing 938, but which is connected to the transceiver via a hermetic feedthrough (not shown).
[0099] The stimulating assembly 916 comprises a plurality of electrodes 944(l)-(3) disposed in a carrier member (e.g., a flexible silicone body). In this specific example, the stimulating assembly 916 comprises three (3) electrodes, referred to as electrodes 944(1), 944(2), and 944(3). The electrodes 944(1), 944(2), and 944(3) function as an electrical interface for delivery of electrical stimulation signals to the recipient’s vestibular system.[ootoo] The stimulating assembly 916 is configured such that a surgeon can implant the stimulating assembly adjacent the recipient’s otolith organs via, for example, the recipient’s oval window. It is to be appreciated that this specific embodiment with three stimulationAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1electrodes 944(l)-944(3) is merely illustrative and that the techniques presented herein can be used with stimulating assemblies having different numbers of stimulation electrodes, stimulating assemblies having different lengths, etc.[ooiot] In operation, the vestibular stimulator system 902 delivers electrical stimulation to the recipient via one or more of the electrodes 944(1), 944(2), and 944(3). The intensity of the electrical stimulation delivered to the recipient can be determined / set using an intensity scaling test that is implemented and / or controlled as described elsewhere herein.
[0102] FIG. 10 illustrates an upper airway stimulation device 1000 (e.g., an upper airway implant, a sleep apnea management stimulator, a sleep disorder system) that includes an implant body 1002, a sensor 1004, and a stimulator 1006. The upper airway stimulation device 1000 is implantable in a recipient 1008 to position the sensor 1004 adjacent to lungs 1010 of the recipient 1008. Thus, the sensor 1004 is able to receive input that indicates breathing performed by the recipient 1008. The implant body 1002 includes a housing in which circuitry, such as a processor and / or a memory, is disposed. The sensor 1004 transmits electrical signals in response to receipt of the input, and the upper airway stimulation device 1000 is configured to convert the electrical signals to stimulation signals, which are provided to the stimulator 1006. The stimulator 1006 is positioned adjacent to a hypoglossal nerve 1012 of the recipient 1008 and is configured to deliver the stimulation signals to the hypoglossal nerve 1012, which fires nerve cells of a tongue of the recipient 1008, thereby causing the tongue to contract and move (e.g., in an anterior direction) and increase a size of an opening of an airway of the recipient 1008. Consequently, the upper airway stimulation device 1000 generates stimulation signals based on the input to help the recipient 1008 breathe more easily (e.g., while the recipient 1008 is asleep to mitigate sleep apnea).
[0103] As noted, in operation, the upper airway stimulation device 1000 delivers electrical stimulation to the recipient. The intensity of the electrical stimulation delivered to the recipient can be determined / set using an intensity scaling test that is implemented and / or controlled as described elsewhere herein.
[0104] FIG. 11 illustrates a tinnitus therapy device 1100 (e.g., a tinnitus implant, a tinnitus management stimulator) including a sound input unit 1102 (e.g., a microphone) configured to receive acoustic inputs. In some embodiments, the sound input unit 1102 is implanted adjacent to an outer ear 1103 to position a diaphragm 1116 of the sound input unit 1102 such that the diaphragm 1116 is configured to be displaced (vibrate) in response to the acoustic inputs. TheAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1tinnitus therapy device 1100 further includes an implant body 1104 in which circuitry, such as a processor and / or a memory, is disposed. The implant body 1104 is also coupled to a coil 1108 to enable transfer of power / data between the tinnitus therapy device 1100 and an external device. The implant body 1104 is electrically coupled to the sound input unit 1102 to receive the acoustic input. The tinnitus therapy device 1100 is then configured to convert the acoustic input to tinnitus therapy control signals (e.g., based on a classification of the acoustic input).
[0105] The tinnitus therapy control signals are provided to an actuator 1106 electrically coupled to the implant body 1104 for delivery to the recipient. By way of example, a coupling member 1140 couples the actuator 1106 to an ossicular chain 1136 (i.e., the malleus, the incus, and the stapes bones) positioned in a middle ear cavity between a tympanic membrane 1113 and a cochlea 1138 of the recipient, and the actuator 1106 is configured to deliver the tinnitus therapy control signals. The actuator 1106 is attached to a temporal bone 1115 of the recipient via a fixation system 1142 and is configured to impart motion to (e.g., vibrate) the ossicular chain 1136, which is typically configured to amplify sound waves received via an ear canal 1111. In operation, the actuator 1106 is configured to impart motion based on the tinnitus therapy control signals, and such vibration creates waves of fluid motion of perilymph within the cochlea 1138 to activate hair cells within the cochlea 1138. Activation of the hair cells causes nerve impulses to be generated and transferred through spiral ganglion cells, an auditory nerve, and a brain, where the vibration is perceived as sounds to provide relief of tinnitus symptoms experienced by the recipient.
[0106] As noted, in operation, tinnitus therapy device 1100 delivers mechanical stimulation to the recipient. The intensity (amplitude) of the mechanical stimulation delivered to the recipient can be determined / set using an intensity scaling test that is implemented and / or controlled as described elsewhere herein.
[0107] FIG. 12 illustrates an example of a computing system 1200 with which one or more of the disclosed examples can be implemented. Computing systems, environments, or configurations that suitable for use with examples described herein include, but are not limited to, personal computers, server computers, hand-held devices, laptop devices, multiprocessor systems, microprocessor-based systems, programmable consumer electronics (e.g., smart phones), network PCs, minicomputers, mainframe computers, tablets, distributed computing environments that include any of the above systems or devices, and the like. The computing system 1200 can be a single virtual or physical device operating in a networked environment over communication links to one or more remote devices. In examples, the recipientAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1stimulation device 110, the user computing device 120, the clinician computing device 130, and the fitting server 140 can include one or more components or variations of components of the computing system 1200.
[0108] In its most basic configuration, computing system 1200 includes memory 1293 and one or more processors 1296. In the illustrated example, the system 1200 further includes a network adapter 1292, one or more input devices 1298, and one or more output devices 1299. The system 1200 can include other components, such as a system bus, component interfaces, a graphics system, a power source (e.g., a battery), among other components.
[0109] The memory 1293 is one or more software- or hardware-based computer-readable storage media operable to store information accessible by the one or more processors 1296. The memory 1293 can store, among other things, instructions executable by the one or more processors 1296 to implement applications or cause performance of operations described herein, as well as other data. The memory 1293 can be volatile memory (e.g., RAM), nonvolatile memory (e.g., ROM), or combinations thereof. The memory 1293 can include transitory memory or non-transitory memory. The memory 1293 can also include one or more removable or non-removable storage devices. In examples, the memory 1293 can include RAM, ROM, EEPROM (Electronically-Erasable Programmable Read-Only Memory), flash memory, optical disc storage, magnetic storage, solid state storage, or any other memory media usable to store information for later access. In examples, the memory 1293 encompasses a modulated data signal (e.g., a signal that has one or more of its characteristics set or changed in such a manner as to encode information in the signal), such as a carrier wave or other transport mechanism and includes any information delivery media. By way of example, and not limitation, the memory 1293 can include wired media such as a wired network or direct-wired connection, and wireless media such as acoustic, RF, infrared and other wireless media or combinations thereof.
[0110] The one or more processors 1296 include one or more hardware or software processors, such as microprocessors, central processing units, etc. In many examples, the one or more processors 1296 are configured to obtain and execute instructions, such as instructions stored in the memory 1293. The one or more processors 1296 can communicate with and control the performance of other components of the computing system 1200.
[0111] The network adapter 1292 is a component of the computing system 1200 that provides network access over a network 1202. The network adapter 1292 can provide wired or wirelessAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1network access and can support one or more of a variety of communication technologies and protocols, such as ETHERNET, cellular, BLUETOOTH, near-field communication, and RF (Radiofrequency), among others. The network adapter 1292 can include one or more antennas and associated components configured for wireless communication according to one or more wireless communication technologies and protocols.
[0112] The one or more input devices 1298 are devices over which the computing system 1200 receives input from a user. The one or more input devices 1298 can include physically-actuatable user-interface elements (e.g., buttons, switches, or dials), touch screens, keyboards, mice, pens, and voice input devices, among others input devices.
[0113] The one or more output devices 1299 are devices by which the computing system 1200 can provide output to a user. The one or more output devices 1299 can include, displays, speakers, and printers, among other output devices.
[0114] As should be appreciated, while particular uses of the technology have been illustrated and discussed above, the disclosed technology can be used with a variety of devices in accordance with many examples of the technology. The above discussion is not meant to suggest that the disclosed technology is only suitable for implementation within systems akin to that illustrated in the figures. In general, additional configurations can be used to practice the processes and systems herein and / or some aspects described can be excluded without departing from the processes and systems disclosed herein.
[0115] This disclosure described some aspects of the present technology with reference to the accompanying drawings, in which only some of the possible aspects were shown. Other aspects can, however, be embodied in many different forms and should not be construed as limited to the aspects set forth herein. Rather, these aspects were provided so that this disclosure was thorough and complete and fully conveyed the scope of the possible aspects to those skilled in the art.
[0116] As should be appreciated, the various aspects (e.g., portions, components, etc.) described with respect to the figures herein are not intended to limit the systems and processes to the particular aspects described. Accordingly, additional configurations can be used to practice the methods and systems herein and / or some aspects described can be excluded without departing from the methods and systems disclosed herein.
[0117] According to certain aspects, systems and non-transitory computer readable storage media are provided. The systems are configured with hardware configured to executeAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1operations analogous to the methods of the present disclosure. The one or more non-transitory computer readable storage media comprise instructions that, when executed by one or more processors, cause the one or more processors to execute operations analogous to the methods of the present disclosure.
[0118] Similarly, where steps of a process are disclosed, those steps are described for purposes of illustrating the present methods and systems and are not intended to limit the disclosure to a particular sequence of steps. For example, the steps can be performed in differing order, two or more steps can be performed concurrently, additional steps can be performed, and disclosed steps can be excluded without departing from the present disclosure. Further, the disclosed processes can be repeated.
[0119] Although specific aspects were described herein, the scope of the technology is not limited to those specific aspects. One skilled in the art will recognize other aspects or improvements that are within the scope of the present technology. Therefore, the specific structure, acts, or media are disclosed only as illustrative aspects. The scope of the technology is defined by the following claims and any equivalents therein.
[0120] It is also to be appreciated that the embodiments presented herein are not mutually exclusive and that the various embodiments can be combined with another in any of a number of different manners.
Claims
Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1CLAIMSWhat is claimed is:
1. A method, comprising:obtaining objective measurement data associated with a recipient of a recipient stimulation device;performing an intensity scaling test during which stimulation is delivered to the recipient via the recipient stimulation device; andcontrolling the intensity scaling test based on the objective measurement data.
2. The method of claim 1, wherein the objective measurement data comprises at least one amplitude growth function (AGF) derived from evoked compound action potential measurements captured from the recipient.
3. The method of claim 1, wherein the objective measurement data comprises electrically evoked stapedius reflex thresholds (eSRTs) captured from the recipient.
4. The method of claim 1, 2, or 3, wherein controlling the intensity scaling test based on the objective measurement data comprises:setting an initial intensity of the stimulation delivered to the recipient during the intensity scaling test based on the objective measurement data.
5. The method of claim 1, 2, or 3, wherein controlling the intensity scaling test based on the objective measurement data comprises:adapting an intensity of the stimulation delivered to the recipient during the intensity scaling test based on subjective feedback from the recipient and the objective measurement data.
6. The method of claim 5, wherein adapting the intensity of the stimulation delivered to the recipient based on subjective feedback from the recipient and the objective measurement data comprises:adapting a rate of change of the intensity or a step size change in the intensity of the stimulation delivered to the recipient.Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC17. The method of claim 1, 2, or 3, wherein controlling the intensity scaling test based on the objective measurement data comprises:using the objective measurement data to determine a predicted loudness growth function for a first electrode of the recipient stimulation device; andimplementing the intensity scaling test to validate the predicted loudness growth function.
8. The method of claim 7, further comprises:determining that the predicted loudness growth function is invalid; andin response to determining that the predicted loudness growth function is invalid, generating a notification to adjust one or more settings of the recipient stimulation device.
9. The method of claim 7, further comprises:determining that the predicted loudness growth function is invalid; andin response to determining that the predicted loudness growth function is invalid, automatically adjusting one or more settings of the recipient stimulation device.
10. The method of claim 1, 2, or 3, wherein performing the intensity scaling test comprises:delivering first stimulation to the recipient via a first electrode of the recipient stimulation device;providing the recipient with a set of response options for rating a perceived relative loudness of the first stimulation;receiving, via the set of response options, an indication of the recipient’s perceived loudness of the first stimulation; anddelivering second stimulation to the recipient via the first electrode, wherein an intensity of the second stimulation is set based on the indication of the recipient’s perceived loudness of the first stimulation and the objective measurement data.
11. The method of claim 1, 2, or 3, further comprising:setting one or more operational settings of the recipient stimulation device based on an outcome of the intensity scaling test; andAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1delivering stimulation to the recipient using the one or more operational settings set based on the outcome of the intensity scaling test.
12. The method of claim 1, 2, or 3, further comprising:during the intensity scaling test, using active learning to adapt one or more parameters of the intensity scaling test.
13. The method of any of claims 1-12, wherein the recipient stimulation device is a hearing device, a sleep disorder, a seizure device, a balance or movement disorder device, a tinnitus management device, or a visual device.
14. A method, comprising:obtaining historical intensity scaling test data associated with a recipient of a recipient stimulation device;determining one or more intensity scaling test parameters based on the historical intensity scaling test data;using the one or more intensity scaling test parameters to administer an intensity scaling test to the recipient via the recipient stimulation device; anddetermining one or more operational settings for the recipient stimulation device based on an outcome of the intensity scaling test.
15. The method of claim 14, further comprising:instantiating the one or more operational settings in the recipient stimulation device.
16. The method of claim 14, wherein the intensity scaling test is performed for a target electrode of the recipient stimulation device, and wherein the historical intensity scaling test data is associated with the target electrode.
17. The method of claim 14, wherein the intensity scaling test is performed for a target electrode of the recipient stimulation device, and wherein the historical intensity scaling test data is associated with an electrode that is different from the target electrode.
18. The method of claim 14, 15, 16, or 17, wherein determining the one or more intensity scaling test parameters based on the historical intensity scaling test data comprises:Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1determining an initial intensity of stimulation delivered to the recipient during the intensity scaling test based on the historical intensity scaling test data.
19. The method of claim 14, 15, 16, or 17, further comprising:obtaining objective measurement data associated with the recipient; and determining the one or more intensity scaling test parameters based on the historical intensity scaling test data and based on the objective measurement data.
20. The method of claim 19, wherein the objective measurement data comprises at least one amplitude growth function (AGF) derived from evoked compound action potential measurements captured from the recipient.
21. The method of claim 19, wherein the objective measurement data comprises electrically evoked stapedius reflex thresholds (eSRTs) captured from the recipient.
22. The method of claim 14, 15, 16, or 17, further comprising:during administration of the intensity scaling test, using active learning to adapt one or more intensity scaling test parameters associated with the intensity scaling test.
23. The method of claim 22, wherein using active learning to adapt the one or more intensity scaling test parameters comprises:using active learning to adapt a rate of change of an intensity or a step size change in the intensity of stimulation delivered to the recipient.
24. The method of any of claims 14-23, wherein the recipient stimulation device is a hearing device, a sleep disorder, a seizure device, a balance or movement disorder device, a tinnitus management device, or a visual device.
25. A method, comprising:obtaining at least one amplitude growth function (AGF) derived from evoked compound action potential measurements of a region of a recipient of a recipient stimulation device;performing a loudness scaling test during which sounds are delivered to the region of the recipient as electrical stimulation; andAtty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1controlling the loudness scaling test based on the at least one amplitude growth function.
26. The method of claim 25, wherein controlling the loudness scaling test based on the at least one amplitude growth function comprises:setting an initial intensity of the electrical stimulation delivered to the region during the loudness scaling test based on the at least one amplitude growth function.
27. The method of claim 25, wherein controlling the loudness scaling test based on the at least one amplitude growth function comprises:adapting an intensity of the electrical stimulation delivered to the region during the loudness scaling test based on subjective feedback from the recipient and the at least one amplitude growth function.
28. The method of claim 27, wherein adapting the intensity of the electrical stimulation delivered to the region based on subjective feedback from the recipient and the at least one amplitude growth function comprises:adapting a rate of change of the intensity or a step size change in the intensity of the electrical stimulation delivered to the region.
29. The method of claim 25, 26, 27, or 28, wherein controlling the loudness scaling test based on the at least one amplitude growth function comprises:using a slope of the at least one amplitude growth function to determine a parameter of the loudness scaling test.
30. The method of claim 25, 26, 27, or 28, wherein controlling the loudness scaling test based on the at least one amplitude growth function comprises:using the at least one amplitude growth function to determine a predicted loudness growth function for a first electrode; andimplementing the loudness scaling test to validate the predicted loudness growth function.
31. The method of claim 25, 26, 27, or 28, wherein performing the loudness scaling test comprises:Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1delivering first stimulation to the region via a first electrode;providing the recipient with a set of response options for rating a perceived relative loudness of the first stimulation;receiving, via the set of response options, an indication of the recipient’s perceived loudness of the first stimulation; anddelivering second stimulation to the region via the first electrode, wherein an intensity of the second stimulation is set based on the indication of the recipient’s perceived loudness of the first stimulation.
32. The method of claim 25, 26, 27, or 28, further comprising:setting one or more operational settings of the recipient stimulation device based on an outcome of the loudness scaling test; anddelivering electrical stimulation to the recipient using the one or more operational settings set based on the outcome of the loudness scaling test.
33. The method of claim 25, 26, 27, or 28, further comprising:during the loudness scaling test, using active learning to adapt one or more parameters of the loudness scaling test.
34. The method of any of claims 25-33, wherein the region is an inner ear of the recipient, and the recipient stimulation device is a hearing device.
35. One or more non-transitory computer readable storage media comprising instructions that, when executed by one or more processors, cause the one or more processors to:obtain objective measurement data associated with a recipient;determine one or more intensity scaling test parameters based on the objective measurement data;deliver, via a recipient stimulation device, first stimulation to the recipient; provide the recipient with a set of response options for rating a perceived relative intensity of the first stimulation;receiving, via the set of response options, an indication of the recipient’s perceived intensity of the first stimulation;Atty. Docket No. 3065.0882i Client Ref. No. CID04081WOPC1determine, using active learning, second stimulation for delivery to the recipient; and deliver, via the recipient stimulation device, the second stimulation to recipient.
36. The one or more non-transitory computer readable storage media of claim 35, wherein the one or more processors are configured to:use active learning to determine an intensity of the second stimulation.
37. The one or more non-transitory computer readable storage media of claim 35, wherein the intensity of the second stimulation is set based on the indication of the recipient’s perceived intensity of the first stimulation and the objective measurement data.
38. The one or more non-transitory computer readable storage media of claim 35, 36, or 37, wherein the objective measurement data comprises at least one amplitude growth function (AGF) derived from evoked compound action potential measurements captured from the recipient.
39. The one or more non-transitory computer readable storage media of claim 35, 36, or 37, wherein the objective measurement data comprises electrically evoked stapedius reflex thresholds (eSRTs) captured from the recipient.
40. The one or more non-transitory computer readable storage media of claim 35, 36, or 37, wherein an intensity of the first stimulation is set based on historical intensity scaling data associated with the recipient.
41. The one or more non-transitory computer readable storage media claim 35, 36, or 37, wherein an intensity of the second stimulation is set using active learning based on the indication of the recipient’s perceived intensity of the first stimulation and the objective measurement data.
